Eyeworld

The library is open to the public five days a week if you'd like to look around. The Athenaeum isn't just a library though, it also doubles as a performance center, presenting an eclectic, year-round schedule of art exhibitions, concerts, lectures, stu- dio art classes through its School of the Arts, tours, and special events. The Athenaeum will be holding a mini-concert on March 28 at noon. It's free of charge. Performing Arts North Park Vaudeville & Candy Shoppe 2031 El Cajon Blvd. 619-220-8663 www.northparkvaudeville.com Known as San Diego's "smallest, sweetest theater," the North Park Vaudeville & Candy Shoppe is an in- timate playhouse specializing in melodramas, acoustic music, and Vaudeville-style variety shows. Bet- ter yet, its concessions stand features more than 100 types of old-fash- ioned candy such as salt-water taffy, candy sticks, root beer barrels, Mary Janes, and old-fashioned candy bars. The tiny playhouse, which only seats about a dozen or so people, also teaches the STARS theater arts program for individuals with devel- opmental challenges. Call for up- coming show information and reservations. The Old Globe 1363 Old Globe Way 619-234-5623 www.theoldglobe.org If period pieces, duels, and iambic pentameter are more your thing, look no further than the Old Globe theatre. This playhouse performs classic plays like Shakespeare's Much Ado About Nothing and Amadeus by Peter Shaffer. Two plays will be on stage the last week of March: Groundswell, a thriller about dia- mond mining set in a small lodge in South Africa, and Rafta, Rafta…, a comedy that examines the genera- tional divide on sex and marriage within a close-knit Indian family liv- ing in London. Cygnet's Old Town Theatre 4040 Twiggs St. 619-337-1525 www.cygnettheatre.com What good is sitting alone in your room? Come to the cabaret. Cygnet's Old Town Theatre is put- ting on Cabaret, the iconic musical by theatre geniuses Kander and Ebb. Cabaret depicts the interlocking sto- ries of a cabaret singer, an American writer, and the citizens of Berlin, all caught up in the swirling maelstrom of a changing society. In the seamy, sleazy Kit Kat Klub, on the eve of Hitler's rise to power, almost any- thing—including love—is possible. Low-priced previews run from March 17 to March 25, and opening night is March 26. © 2010 Alcon, Inc. 10/10 NPF10504JAD ® NEVANAC® (nepafenac ophthalmic suspension) 0.1%, topical ophthalmic Initial U.S. Approval: 2005 Revised: 9/2007 BRIEF SUMMARY 1 INDICATIONS AND USAGE NEVANAC® ophthalmic suspension is indicated for the treatment of pain and in!ammation associated with cataract surgery. 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosing One drop of NEVANAC® should be applied to the a"ected eye(s) three-times-daily beginning 1 day prior to cataract surgery, continued on the day of surgery and through the #rst 2 weeks of the postoperative period. 2.2 Use with Other Topical Ophthalmic Medications NEVANAC® may be administered in conjunc- tion with other topical ophthalmic medica- tions such as beta-blockers, carbonic anhydrase inhibitors, alpha-agonists, cycloplegics, and mydriatics. 3 DOSAGE FORMS AND STRENGTHS Sterile ophthalmic suspension: 0.1% 3 mL in a 4 mL bottle 4 CONTRAINDICATIONS NEVANAC® is contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formula or to other NSAID. 5 WARNINGS AND PRECAUTIONS 5.1 Increased Bleeding Time With some nonsteroidal anti-in!ammatory drugs including NEVANAC®, there exists the potential for increased bleeding time due to interference with thrombocyte aggregation. There have been reports that ocularly applied nonsteroidal anti-in!ammatory drugs may cause increased bleeding of ocular tissues (including hyphemas) in conjunction with ocular surgery. It is recommended that NEVANAC® ophthalmic suspension be used with caution in patients with known bleeding tendencies or who are receiving other medications which may prolong bleeding time. 5.2 Delayed Healing Topical nonsteroidal anti-in!ammatory drugs (NSAIDs) including NEVANAC®, may slow or delay healing. Topical corticosteroids are also known to slow or delay healing. Concomitant use of topical NSAIDs and topical steroids may increase the potential for healing problems. 5.3 Corneal E!ects Use of topical NSAIDs may result in keratitis. In some susceptible patients, continued use of topical NSAIDs may result in epithelial breakdown, corneal thinning, corneal erosion, corneal ulceration or corneal perforation. These events may be sight threatening. Patients with evidence of corneal epithelial breakdown should immediately discontinue use of topical NSAIDs including NEVANAC® and should be closely monitored for corneal health. Postmarketing experience with topical NSAIDs suggests that patients with complicated ocular surgeries, corneal denervation, corneal epithelial defects, diabetes mellitus, ocular surface diseases (e.g., dry eye syndrome), rheumatoid arthritis, or repeat ocular surgeries within a short period of time may be at increased risk for corneal adverse events which may become sight threatening. Topical NSAIDs should be used with caution in these patients. Postmarketing experience with topical NSAIDs also suggests that use more than 1 day prior to surgery or use beyond 14 days post surgery may increase patient risk and severity of corneal adverse events. 5.4 Contact Lens Wear NEVANAC® should not be administered while using contact lenses. 6 ADVERSE REACTIONS Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to the rates in the clinical studies of another drug and may not re!ect the rates observed in practice. 6.1 Ocular Adverse Reactions The most frequently reported ocular adverse reactions following cataract surgery were capsular opacity, decreased visual acuity, foreign body sensation, increased intraocular pressure, and sticky sensation. These events occurred in approximately 5 to 10% of patients. Other ocular adverse reactions occurring at an incidence of approximately 1 to 5% included conjunctival edema, corneal edema, dry eye, lid margin crusting, ocular discomfort, ocular hyperemia, ocular pain, ocular pruritus, photophobia, tearing and vitreous detachment. Some of these events may be the consequence of the cataract surgical procedure. 6.2 Non-Ocular Adverse Reactions Non-ocular adverse reactions reported at an incidence of 1 to 4% included headache, hypertension, nausea/vomiting, and sinusitis. See full prescribing information for NEVANAC®. ALCON LABORATORIES, INC. Fort Worth, Texas 76134 USA © 2007, 2008 Alcon, Inc. Performing arts continued from P. 31

• Cover